Second-Line Chemotherapy of Advanced Disseminated Gastric Cancer after Cisplatin, Infusional 5-Fluorouracil, Folinic Acid (PLF): Benefit Dependant on Progression-Free Interval after First-Line Therapy
作者： Michael Stahl , Christian Müller , Wolf Köster , Hansjochen Wilke
DOI: 10.1159/000087136
关键词:
摘要: Background: The role of second-line chemotherapy in gastric cancer is not yet established. We analyzed patients receiving treatment after chemotherapy with cisplatin, infusional 5-fluor
sci-hub.se 参考文章(8)
Andre M. Murad, Flavia F. Santiago, Andy Petroianu, Paulo R. S. Rocha, Marco A. G. Rodrigues, Marcelo Rausch, Modified therapy with 5‐fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer Cancer. ,vol. 72, pp. 37- 41 ,(1993) , 10.1002/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P
S Pyrhönen, T Kuitunen, P Nyandoto, M Kouri, Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. British Journal of Cancer. ,vol. 71, pp. 587- 591 ,(1995) , 10.1038/BJC.1995.114
K.E. Schmid, G.V. Kornek, B. Schüll, M. Raderer, A. Lenauer, D. Depisch, F. Lang, W. Scheithauer, Second-line treatment of advanced gastric cancer with oxaliplatin plus raltitrexed. Onkologie. ,vol. 26, pp. 255- 258 ,(2003) , 10.1159/000071621
F. Graziano, V. Catalano, A.M. Baldelli, P. Giordani, E. Testa, V. Lai, G. Catalano, N. Battelli, S. Cascinu, A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer Annals of Oncology. ,vol. 11, pp. 1263- 1266 ,(2000) , 10.1023/A:1008373814453
A.D. Roth, Chemotherapy in gastric cancer: a never ending saga Annals of Oncology. ,vol. 14, pp. 175- 177 ,(2003) , 10.1093/ANNONC/MDG081
L. Assersohn, G. Brown, D. Cunningham, C. Ward, J. Oates, J.S. Waters, M.E. Hill, A.R. Norman, Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma Annals of Oncology. ,vol. 15, pp. 64- 69 ,(2004) , 10.1093/ANNONC/MDH007
B. Glimelius, K. Ekström, K. Hoffman, W. Graf, P.-O. Sjödén, U. Haglund, C. Svensson, L.-K. Enander, T. Linné, H. Sellsröm, R. Heuman, Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer Annals of Oncology. ,vol. 8, pp. 163- 168 ,(1997) , 10.1023/A:1008243606668
P. Ross, M. Nicolson, D. Cunningham, J. Valle, M. Seymour, P. Harper, T. Price, H. Anderson, T. Iveson, T. Hickish, F. Lofts, A. Norman, Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer Journal of Clinical Oncology. ,vol. 20, pp. 1996- 2004 ,(2002) , 10.1200/JCO.2002.08.105